April 03, 2026 12:23 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
AAP drops Raghav Chadha from key parliamentary role, sparks buzz over internal rift | Amit Shah to camp in West Bengal for 15 days during Assembly polls; predicts Mamata’s defeat in state and Bhabanipur | 'BJP plotting President’s Rule, don’t fall in the trap': Mamata Banerjee on Malda unrest, urges peace | 'Most polarised state': CJI Kant raps Bengal govt over 9-hour hostage of judicial officers | Bengal SIR protest: Judge pleads for help amid mob attack after 9-hour hostage ordeal | Bengal SIR progress: 47 lakh of 60 lakh adjudicated cases disposed of, Supreme Court informed | Amit Shah to join Suvendu Adhikari on Bhabanipur nomination day; BJP plans mega roadshow | Fuel prices rise: Premium petrol, diesel hiked amid oil price surge | Commercial LPG up Rs 195.50 as global oil prices rise; domestic rates unchanged | Layoff alert: Oracle cuts 30,000 jobs globally, 12,000 hit in India
Cancer
Photo: PR Team

Top doctors, new hope: What emerged from the Blood Club Education Conclave

| @indiablooms | Dec 19, 2025, at 06:11 pm

The HCG Cancer Centre, Kolkata, organized “Blood Club Education Conclave”, offered a focused platform for showcasing the newest breakthroughs in bloodcancer treatment. 

It united renowned haematooncology specialists, bone marrow transplant (BMT) physicians and survivors, creating a space for dialogue, awareness building, and an insight into the rapidly evolving therapeutic landscape in cancer treatment.

The conclave commenced with addressing the media, followed by an insightful panel discussion featuring senior clinicians from HCG Cancer Centre’s Haemato-Onco & BMT department along with some eminent external specialists.

The discussions held at the conclave focused on boosting clinical awareness, fostering collaborative learning, and deepening understanding of evolving blood cancer management practices, with emphasis on multidisciplinary collaboration and patient-centric care.

A key highlight of the conclave was the presentation of cutting-edge treatment technologies, including CliniMACS and CAR-T Cell Therapy. Experts shared insights into how these advanced therapies are transforming outcomes by enabling more precise, personalized, and effective treatment options for patients with complex blood disorders.

Another compelling aspect of the conclave was the participation of blood cancer survivors, who shared real-world recovery stories highlighting the importance of timely diagnosis and access to advanced treatment. Three patients shared their journeys - one survivor from Kolkata attended in person, while survivors from Mumbai and Myanmar joined virtually via video link - adding a powerful human dimension to the scientific discussions.

Gurvinder Singh, Chief Operating Officer, HCG EKO Cancer Center, Kolkata, said, “The Blood Club Education Conclave reflects HCG’s commitment to advancing clinical knowledge, encouraging collaboration among specialists, and amplifying patient voices. By bringing clinicians, survivors, and the media together on a single platform, we aim to build greater awareness around modern blood cancer treatments and reinforce hope for patients and their families.”

Dr. Joydeep Chakraborty, HOD & Senior Consultant – Haemato Oncology and Bone Marrow Transplant, HCG Cancer Center, Kolkata, said, “With rapid medical advancements, such as CAR-T Cell Therapy and CliniMACS, the treatment of blood cancers has entered into a transformative phase. The HCG organized conclave has provided an opportunity to exchange knowledge, discuss real-world outcomes, and ensure that patients benefit from the most advanced, evidence-based care available today.”

The Blood Club Education Conclave concluded with an interactive networking session over cocktails and dinner, enabling meaningful engagement between doctors, media, and key stakeholders. The initiative reaffirmed HCG’s focus on continuous medical education, innovation-driven care, and patient-centric outcomes in the field of blood cancer treatment.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.